ESTC insider sale notice: 1,256 shares on NYSE for $106,232

Rhea-AI Filing Summary

Form 144 notice for Elastic N.V. (ESTC) records a proposed sale of 1,256 common shares with an aggregate market value of $106,232.48, to be executed through Morgan Stanley Smith Barney LLC on 10/06/2025 on the NYSE. The sale is listed as shares acquired as restricted stock on 09/08/2025 with payment dated the same day. The filing also discloses a prior sale by NAVAM WELIHINDA of 3,489 common shares on 09/09/2025 for $314,432.96. The filer represents they lack undisclosed material adverse information and includes the standard Rule 10b5-1 notice language.

Positive

• Sale will be executed through a major broker (Morgan Stanley Smith Barney LLC), indicating orderly market handling
• Form 144 filed in advance of the proposed sale date, complying with disclosure requirements

Negative

• Insider-related selling activity includes 1,256 shares proposed and a recent 3,489 share sale, which may raise investor attention to insider liquidity
• Issuer name and filer CIK details are not provided within the notice tables, limiting traceability of the specific filing party in the document

Insights

Equity Transactions Analyst

Insider-related sales modest in size and recent; monitor timing and pattern.

The notice shows a proposed sale of $106,232.48 for 1,256 shares scheduled on 10/06/2025

The transaction will route through Morgan Stanley Smith Barney LLC and follows a separate sale of 3,489 shares on 09/09/2025 that generated $314,432.96. Concentrated short-window sales can matter for market perception; watch for additional filings in the next 45 days for aggregated activity.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1256	106232.48	106270940	10/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2025	Restricted Stock	ISSUER			1256	09/08/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NAVAM WELIHINDA 88 Kearny St. Floor 19 San Francisco CA 94108	COMMON	09/09/2025	3489	314432.96

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Elastic N.V. (ESTC) Form 144 disclose?

It discloses a proposed sale of 1,256 common shares valued at $106,232.48 to be sold on 10/06/2025 via Morgan Stanley Smith Barney LLC.

Who previously sold shares according to the filing?

NAVAM WELIHINDA sold 3,489 common shares on 09/09/2025 for $314,432.96.

How were the 1,256 shares acquired that are to be sold?

The shares are listed as restricted stock acquired from the issuer on 09/08/2025 with payment dated 09/08/2025.

On which exchange will the proposed sale occur?

The filing lists the NYSE as the named securities exchange for the proposed 10/06/2025 sale.

Does the filer assert any material nonpublic information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.